SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/10/22 Skinvisible, Inc. 10-Q 6/30/22 46:2.2M Edgar Einsteins, Inc./FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 380K 7: EX-31.1 Certification -- §302 - SOA'02 HTML 18K 8: EX-31.2 Certification -- §302 - SOA'02 HTML 18K 9: EX-32.1 Certification -- §906 - SOA'02 HTML 15K 10: R1 Cover HTML 63K 11: R2 Consolidated Balance Sheets HTML 107K 12: R3 Consolidated Balance Sheets (Parenthetical) HTML 28K 13: R4 Consolidated Statements of Operations (Unaudited) HTML 91K 14: R5 Consolidated Statements of Stockholders' Deficit HTML 47K (Unaudited) 15: R6 Consolidated Statements of Cash Flows (Unaudited) HTML 41K 16: R7 1. Description of Business and History HTML 19K 17: R8 2. Basis of Presentation and Going Concern HTML 21K 18: R9 3. Summary of Significant Policies HTML 35K 19: R10 4. Intangible and Other Assets HTML 18K 20: R11 5. Related Party Transactions HTML 30K 21: R12 6. Notes Payable HTML 22K 22: R13 7. Convertible Notes Payable HTML 35K 23: R14 8. Stock Options and Warrants HTML 29K 24: R15 9. Commitments and Contingencies HTML 24K 25: R16 10. Stockholders? Deficit HTML 23K 26: R17 11. Subsequent Events HTML 17K 27: R18 2. Basis of Presentation and Going Concern HTML 23K (Policies) 28: R19 3. Summary of Significant Policies (Policies) HTML 58K 29: R20 5. Related Party Transactions (Tables) HTML 26K 30: R21 8. Stock Options and Warrants (Tables) HTML 27K 31: R22 1. Description of Business and History (Details HTML 16K Narrative) 32: R23 2. Basis of Presentation and Going Concern HTML 27K (Details Narrative) 33: R24 3. Summary of Significant Policies (Details HTML 25K Narrative) 34: R25 4. Intangible and Other Assets (Details Narrative) HTML 22K 35: R26 5. RELATED PARTY TRANSACTIONS - Schedule of HTML 60K Convertible Notes Payable Related Party (Details) 36: R27 5. Related Party Transactions (Details Narrative) HTML 24K 37: R28 6. Notes Payable (Details Narrative) HTML 26K 38: R29 7. Convertible Notes Payable (Details Narrative) HTML 75K 39: R30 8. STOCK OPTIONS AND WARRANTS - Schedule of Option HTML 45K Summary (Details) 40: R31 9. Commitments and Contingencies (Details HTML 26K Narrative) 41: R32 10. Stockholders? Deficit (Details Narrative) HTML 23K 44: XML IDEA XML File -- Filing Summary XML 76K 42: XML XBRL Instance -- skvi10q_htm XML 384K 43: EXCEL IDEA Workbook of Financial Reports XLSX 64K 3: EX-101.CAL XBRL Calculations -- skvi-20220630_cal XML 74K 4: EX-101.DEF XBRL Definitions -- skvi-20220630_def XML 157K 5: EX-101.LAB XBRL Labels -- skvi-20220630_lab XML 426K 6: EX-101.PRE XBRL Presentations -- skvi-20220630_pre XML 351K 2: EX-101.SCH XBRL Schema -- skvi-20220630 XSD 70K 45: JSON XBRL Instance as JSON Data -- MetaLinks 189± 266K 46: ZIP XBRL Zipped Folder -- 0001663577-22-000441-xbrl Zip 128K
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Skinvisible, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2022 filed with the Securities and Exchange Commission (the “Report”), I, Terry Howlett, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented. |
By: | /s/ Terry Howlett |
Name: | Terry Howlett |
Title: | Principal Executive Officer, Principal Financial Officer and Director |
Date: | August 10, 2022 |
This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/10/22 | None on these Dates | ||
For Period end: | 6/30/22 | |||
List all Filings |